In a study done by Hao et al., delivering miRNA-15a and miRNA-16-1 mimics using ATE conjugated with RNA aptamer that targets prostate-specific membrane antigen (PSMA) expressed by some PCa types inhibited the growth of bone-metastatic prostate tumor mouse model [211]. This evidence concerns the gene FOLH1 and prostate neoplasm.